Siloam Hospitals - Public Comps and Valuation Multiples

Siloam Hospitals Overview

About Siloam Hospitals

PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. The company manages and operates multiple hospitals in Jadebotabek. Siloam Hospitals makes investments in both technology and medical staff to offer a range of medical services. The company also manages Centers of Excellence that address medical cases requiring complex treatment. The company derives its revenue from inpatient and outpatient services. Inpatient services derive revenue from medical support and medical specialist services, drugs and medical supplies, and inpatient rooms. Outpatient services derive revenue from the delivery of medical support and medical specialist services; drugs and medical supplies; hospital facilities. Inpatient services are responsible for a majority of company revenue.

Founded

1996

HQ

Employees

Website

siloamhospitals.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $755M

LTM EBITDA $186M

EV

$1.8B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Siloam Hospitals Financials

Siloam Hospitals has a last 12-month revenue of $755M and a last 12-month EBITDA of $186M.

In the most recent fiscal year, Siloam Hospitals achieved revenue of $726M and an EBITDA of $136M.

Siloam Hospitals expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Siloam Hospitals valuation multiples based on analyst estimates

Siloam Hospitals P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$666M	$726M	XXX	XXX	XXX
Gross Profit	$210M	$265M	XXX	XXX	XXX
Gross Margin	32%	36%	XXX	XXX	XXX
EBITDA	$150M	$136M	XXX	XXX	XXX
EBITDA Margin	23%	19%	XXX	XXX	XXX
Net Profit	$41.4M	$72.1M	XXX	XXX	XXX
Net Margin	6%	10%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Siloam Hospitals Stock Performance

As of April 28, 2025, Siloam Hospitals's stock price is IDR 2270 (or $0).

Siloam Hospitals has current market cap of IDR 29.47T (or $1.8B), and EV of IDR 30.08T (or $1.8B).

See Siloam Hospitals trading valuation data

Siloam Hospitals Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.8B	$1.8B	XXX	XXX	XXX	XXX	$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Siloam Hospitals Valuation Multiples

As of April 28, 2025, Siloam Hospitals has market cap of $1.8B and EV of $1.8B.

Siloam Hospitals's trades at 2.4x LTM EV/Revenue multiple, and 9.6x LTM EBITDA.

Analysts estimate Siloam Hospitals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Siloam Hospitals and 10K+ public comps

Siloam Hospitals Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$1.8B	XXX	XXX	XXX
EV/Revenue	2.5x	XXX	XXX	XXX
EV/EBITDA	13.2x	XXX	XXX	XXX
P/E	32.7x	XXX	XXX	XXX
P/E/Growth	0.9x	XXX	XXX	XXX
EV/FCF	43.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Siloam Hospitals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Siloam Hospitals Valuation Multiples

Siloam Hospitals's NTM/LTM revenue growth is 12%

Siloam Hospitals's revenue per employee for the last fiscal year averaged $51.9M, while opex per employee averaged $12.9M for the same period.

Over next 12 months, Siloam Hospitals's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Siloam Hospitals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Siloam Hospitals and other 10K+ public comps

Siloam Hospitals Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	9%	XXX	XXX	XXX	XXX
EBITDA Margin	19%	XXX	XXX	XXX	XXX
EBITDA Growth	-10%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	31%	XXX	XXX	XXX	XXX
Revenue per Employee	$51.9M	XXX	XXX	XXX	XXX
Opex per Employee	$12.9M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	1%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	7%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	25%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Explore Valuation Multiples by Industry